CNS Focused Specialty Medicines

Learn more

Our Vision

Our Vision: To lead the development and delivery of value added medicines in the central nervous system segment.

Learn more

Our Mission

Our Mission: To improve existing CNS therapies by building breakthrough intellectual property in collaboration with global partners.

Learn more
Who We Are

A specialty pharmaceutical company dedicated to developing and delivering value added medicines in the neurology space.

Value Added Products
Improved Patient Benefits
Strong Intellectual Property
High Quality Standards

About Us

Spekar Therapeutics is a specialty pharmaceutical company focused on licensing, developing and commercializing value-added formulations in the central nervous system space.

We optimize established molecules by reformulating or repositioning them towards new indications with improved clinical benefits. Our goal is to provide patients with products that offer better safety, efficacy and convenience over existing treatments while delivering them in a cost-effective manner.

Spektar utilizes an asset light business model that leverages a wide network of third-party research and manufacturing partners to develop our proprietary formulations. We partner with leading pharmaceutical companies to ensure our products are delivered to patients across the globe with the best standards of quality and compliance.

Why CNS?

The central nervous system (CNS) segment has seen one of the lowest rates of new drug approvals across therapeutic categories in the last few decades. This is due to low rates of clinical success and high costs of developing new molecular entities, specifically in the psychiatry and neurodegenerative areas.

Our value-added formulations provide partners and patients with much needed improvements in standard of care treatments that have not seen any improvement in several decades.

Our main indications of focus:

  • Major Depression Disorder
  • Bipolar Disorder
  • Schizophrenia
  • Movement Disorders

Partnership & Collaboration Model

We are constantly on the lookout for new technologies and partners that can help expand our portfolio or deliver them to a broader range of patients.

Spektar works with partners across the following areas of the pharmaceutical value chain:

  • Non-clinical and clinical researchers
  • Formulation development partners
  • API manufacturing suppliers
  • Finished goods contract manufacturers
  • Commercial and marketing organizations